Search Results

FDA Approves First Treatment for Rare Noncancerous Tumors.

Subjects: TUMOR treatment; DISEASE progression; PAIN

• Source: Formulary Watch. 11/28/2023, p1-1. 1p.

Record details

Physical, psychological, social, and spiritual aspects of end-of-life trajectory among patients with advanced cancer: A phenomenological inquiry.

• Authors : Lee, Geok Ling; Ramaswamy, Akhileswaran

Subjects: TUMOR treatment; BASIC needs; CANCER patient psychology

• Source: Death Studies. 2020, Vol. 44 Issue 5, p292-302. 11p. 2 Charts.

Record details

Targeting Cytotoxic T Cells to Tumor.

• Authors : Phimister, Elizabeth G.; Rubin, Eric J.

Subjects: TUMOR treatment; THERAPEUTIC use of antineoplastic agents; TUMORS

• Source: New England Journal of Medicine. 6/2/2022, Vol. 386 Issue 22, p2145-2148. 4p.

Record details

Turbocharging the T Cell to Fight Cancer.

• Authors : Schietinger, Andrea

Subjects: TUMOR treatment; T cells

• Source: New England Journal of Medicine. 6/16/2022, Vol. 386 Issue 24, p2334-2336. 3p.

Record details

THE T-CELL ARMY.

• Authors : GROOPMAN, JEROME

Subjects: CANCER treatment; TUMOR treatment; T cells

• Source: New Yorker. 4/23/2012, Vol. 88 Issue 10, p24-30. 6p. 1 Color Photograph, 1 Black and White Photograph.

Record details

In vivo discovery of immunotherapy targets in the tumour microenvironment.

• Authors : Zhou, Penghui; Shaffer, Donald R.; Alvarez Arias, Diana A.

Subjects: IMMUNOTHERAPY; TUMOR treatment; RNA

• Source: Nature. 2/6/2014, Vol. 506 Issue 7486, p52-57. 6p. 1 Diagram, 1 Chart, 5 Graphs.

Record details

SEEK AND DESTROY.

• Authors : SCHOENBERGER, STEPHEN P.; COHEN, EZRA

Subjects: CANCER treatment; TUMOR treatment; IMMUNOTHERAPY

• Source: Scientist. Apr2017, Vol. 31 Issue 4, p48-53. 6p.

Record details

Tumor Microenvironment, Metabolism, and Immunotherapy.

• Authors : DeBerardinis, Ralph J.

Subjects: TUMOR treatment; GLUTAMINE metabolism; ANIMALS

• Source: New England Journal of Medicine. 2/27/2020, Vol. 382 Issue 9, p869-871. 3p.

Record details

Hospitals, cancer centers chafe at CMS' approach to national CAR-T coverage.

• Authors : King, Robert

Subjects: TUMOR treatment; CANCER treatment; CELL receptors

• Source: Modern Healthcare. 4/22/2019, Vol. 49 Issue 16, p13-13. 1p.

Record details

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

• Authors : Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A.

Subjects: ANTINEOPLASTIC agents; BRAIN tumor treatment; GLIOMA treatmentCANADA; EUROPE; ISRAEL

• Source: JAMA: Journal of the American Medical Association. 12/15/2015, Vol. 314 Issue 23, p2535-2543. 9p. 1 Diagram, 2 Charts, 1 Graph.

Record details